These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3143903)

  • 1. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK; Simons JA
    Med Pediatr Oncol; 1988; 16(6):372-4. PubMed ID: 3143903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
    J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants.
    Nicolau DP; Hogan KR
    Mayo Clin Proc; 1992 Jun; 67(6):611-2. PubMed ID: 1434892
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
    Hows JM; Mehta A; Ward L; Woods K; Perez R; Gordon MY; Gordon-Smith EC
    Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation.
    Jaiswal SR; Singhal P; Thatai A; Bhagwati G; Aiyer HM; Chakrabarti A; Chakrabarti S
    Ann Hematol; 2020 Apr; 99(4):839-845. PubMed ID: 32025839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
    Czownicki Z; Utracka-Hutka B
    Nowotwory; 1981; 30(4):377-83. PubMed ID: 6792599
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical overview of mesna.
    Burkert H
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():175-81. PubMed ID: 6414692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice.
    Song J; Liu L; Li L; Liu J; Song E; Song Y
    Cell Biochem Funct; 2014 Mar; 32(2):125-32. PubMed ID: 23650119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
    Shepherd JD; Pringle LE; Barnett MJ; Klingemann HG; Reece DE; Phillips GL
    J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
    Link H; Neef V; Niethammer D; Wilms K
    Blut; 1981 Nov; 43(5):329-30. PubMed ID: 6799018
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study.
    Saito Y; Kumamoto T; Shiraiwa M; Sonoda T; Arakawa A; Hashimoto H; Tamai I; Ogawa C; Terakado H
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e460-e464. PubMed ID: 29989294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
    J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data).
    Hows J; Mehta A; Gordon-Smith EC
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hemorrhagic cystitis after cyclophosphamide therapy with or without mesna: A cohort study and comprehensive literature review.
    Almalag HM; Alasmari SS; Alrayes MH; Binhameed MA; Alsudairi RA; Alosaimi MM; Alnasser GA; Abuzaid RA; Khalil N; Abouzaid HH; Alarfaj AS
    J Oncol Pharm Pract; 2021 Mar; 27(2):340-349. PubMed ID: 32356687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].
    Marti C; Steiner R; Viollier AF
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1885-7. PubMed ID: 119317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.
    Vose JM; Reed EC; Pippert GC; Anderson JR; Bierman PJ; Kessinger A; Spinolo J; Armitage JO
    J Clin Oncol; 1993 Jul; 11(7):1306-10. PubMed ID: 8315426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the uroprotective efficacy of mesna and HBO treatments in cyclophosphamide-induced hemorrhagic cystitis.
    Etlik O; Tomur A; Deveci S; Pişkin I; Pekcan M
    J Urol; 1997 Dec; 158(6):2296-9. PubMed ID: 9366379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna.
    Morais MM; Belarmino-Filho JN; Brito GA; Ribeiro RA
    Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.